Related references
Note: Only part of the references are listed.NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors
Vivian Y. Shin et al.
CARCINOGENESIS (2011)
Prognostic Implications of miR-16 Expression Levels in Resected Non-Small-Cell Lung Cancer
Alfons Navarro et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
Ulf Klein et al.
CANCER CELL (2010)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
R. I. Aqeilan et al.
CELL DEATH AND DIFFERENTIATION (2010)
A New Therapy Paradigm for Prostate Cancer Founded on Clinical Observations
Eleni Efstathiou et al.
CLINICAL CANCER RESEARCH (2010)
Tumor-stroma co-evolution in prostate cancer progression and metastasis
Sajni Josson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Aldo M. Roccaro et al.
BLOOD (2009)
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Resham Bhattacharya et al.
CANCER RESEARCH (2009)
miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer
Nora Bandi et al.
CANCER RESEARCH (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The VEGF IRESes are differentially susceptible to translation inhibition by miR-16
Zeineb S. Karaa et al.
RNA (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Minireview: Regulation of prostatic stem cells by stromal niche in health and disease
Gail P. Risbridger et al.
ENDOCRINOLOGY (2008)
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Desiree Bonci et al.
NATURE MEDICINE (2008)
Fibroblast growth factor-2 mediates transforming growth factor-β action in prostate cancer reactive stroma
F. Yang et al.
ONCOGENE (2008)
Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2
S. F. Winter et al.
ONCOGENE (2007)
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic
Mingfang Ao et al.
CANCER RESEARCH (2007)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo et al.
NATURE REVIEWS CANCER (2007)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
The role of fibroblast growth factors and their receptors in prostate cancer
B Kwabi-Addo et al.
ENDOCRINE-RELATED CANCER (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice
QM He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
'Advanced' generation lentivirruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo
D Bonci et al.
GENE THERAPY (2003)
Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches
RJA van Moorselaar et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin
JA Smith et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
O Sezer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs
SH Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
